GynecologyNews.net

Gynecology Xagena

XagenaNewsletter
Medical Meeting
Xagena Mappa
Onco News

Hormone replacement therapy ( HRT ) using oestrogen and progestin increases the risk of death from lung cancer. This finding should be incorporated into risk-benefit discussions for women considering ...


Women with a deleterious gene mutation are diagnosed with breast carcinoma six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer.The findings, pres ...


Aromatase inhibitors carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, h ...


The results of a study have shown a possible association between endometriosis and periodontal disease.Endometriosis occurs when the tissue lining the uterus, the endometrium, begins to grow and shed ...


Three drugs that reduce a woman's chance of getting mammary carcinoma also have been shown to cause adverse effects, according to a new report from the Agency for Healthcare Research and Quality ( AHR ...


Tibolone ( Livial ), a synthetic steroid used to treat menopausal symptoms and to prevent osteoporosis, significantly increases the risk of recurrence for breast cancer patients.Tibolone should not, t ...


Women with a family history of breast cancer were 59 percent less likely to develop breast cancer themselves if they breastfed their children.Among women with a mother or sister with breast cancer, th ...


Researchers from the Sanford School of Medicine at The University of South Dakota have demonstrated that mifepristone prevents regrowth of ovarian cancer cells that survive standard chemotherapy. “Uti ...


Two separate meta-analyses of clinical trials that tested Tamoxifen ( Nolvadex ) against aromatase inhibitors in postmenopausal women with early breast cancer have each reached the same conclusion: ar ...


Researchers at The University of Texas MD Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs ...


New results from the Women's Health Initiative ( WHI ) have confirmed that the health risks of long-term use of combination ( Estrogen plus Progestin ) hormone therapy in healthy, postmenopausal women ...


Pregnancy alone does not appear to be associated with an increased risk of the most prevalent mental disorders. However, post-partum women may have a higher risk of major depressive disorder. Preg ...


During hysterectomy operations, surgeons often remove a woman's ovaries as well as her uterus. Cochrane Researchers now say there is no evidence that removing the ovaries provides any additional benef ...


Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast ca ...


The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sl ...